Whitehawk Therapeutics (WHWK) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.91% |
| Dec 31, 2025 | 58.92% |
| Sep 30, 2025 | -48.98% |
| Jun 30, 2025 | -51.25% |
| Mar 31, 2025 | -29.90% |
| Dec 31, 2024 | -32.40% |
| Sep 30, 2024 | -21.98% |
| Jun 30, 2024 | -21.12% |
| Mar 31, 2024 | -17.15% |
| Dec 31, 2023 | -14.85% |
| Sep 30, 2023 | -29.16% |
| Jun 30, 2023 | -26.49% |
| Mar 31, 2023 | -17.61% |
| Dec 31, 2022 | -19.73% |
| Sep 30, 2022 | -25.88% |
| Jun 30, 2022 | -26.88% |
| Mar 31, 2022 | -23.75% |
| Dec 31, 2021 | -36.99% |
| Sep 30, 2021 | -79.04% |
| Jun 30, 2021 | 2.41% |
| Mar 31, 2021 | 0.57% |
| Dec 31, 2020 | 287.73% |
| Sep 30, 2020 | -261.26% |
| Jun 30, 2020 | 348.55% |
| Mar 31, 2020 | -301.13% |
| Dec 31, 2019 | -243.33% |
| Sep 30, 2019 | -301.42% |
| Jun 30, 2019 | -307.71% |
| Mar 31, 2019 | -363.39% |
| Dec 31, 2018 | -305.50% |
| Sep 30, 2018 | 378.34% |
| Jun 30, 2018 | -306.24% |
| Mar 31, 2018 | -334.90% |
| Dec 31, 2017 | -275.93% |
| Sep 30, 2017 | -298.16% |
| Jun 30, 2017 | -306.50% |
| Mar 31, 2017 | -307.59% |
| Dec 31, 2016 | -233.38% |
| Sep 30, 2016 | -287.52% |
| Jun 30, 2016 | -275.52% |
| Mar 31, 2016 | -296.97% |
| Dec 31, 2015 | -5.91% |
| Sep 30, 2015 | -0.42% |